Status: Recruiting
A Small Sample Prospective Clinical Study of Azvudine Tablets to Promote Clinical Cure in Patients With Chronic Hepatitis B
Through regular monitoring of viral load, liver function and immune cell activity, the long-term efficacy of Adefovir in controlling HBV is precisely evaluated. By employing a dual mechanism of "antiviral action plus immune activation", it offers a novel therapeutic option for achieving clinical cure in chronic hepatitis B.
Participants needed: 120
Trial details
Phase: Phase 3Age: 18-65Biological sex: AllType: InterventionalSponsor: Zhigang RenUpdated: Dec 29, 2025Locations: 1
Eligibility criteria
Meet the diagnostic criteria for viral hepatitis as outlined in the Chinese Medi... [+3]
Individuals co-infected with other hepatotropic viruses, such as hepatitis A, C,... [+8]